Interim relief to Novartis: Delhi HC reinstates Entresto (Sacubitril-Valsartan) patent in India Farhat Nasim27 Jan 2023 12:56 PM GMTDelhi: In an interim relief to Swiss pharma major Novartis, the Delhi High Court has reinstated Entresto (sacubitril/valsartan) patent in India amid...
Novartis in tight spot as HC stays grant of patent for Entresto amid generics fight Farhat Nasim13 Jan 2023 6:29 AM GMTNew Delhi: Amid the earlier patent of blockbuster heart failure drug Entresto expiring on January 16, 2023 concerns rise for the Swiss multinational...
Critical Heart Failure drug gets Cheaper, JB Pharma cuts prices of Azmarda by 50 percent Dr. Nandita Mohan8 Dec 2022 7:33 AM GMTMumbai: Treatment of Heart Failure will get more affordable in India, as makers of the heart failure drug Azmarda, JB pharma, has announced a...
JB Pharma slashes price of critical Heart Failure medicine AZMARDA (Sacubitril-Valsartan) by nearly 50 percent Ruchika Sharma5 Dec 2022 9:07 AM GMT"This move by JB will not only help reduce the cost of treatment but will also help enhance the productive years of patients and their quality of...
Long acting Ivabradine improves cardiac function in heart failure patients: FIRST study dr. Abhimanyu Uppal3 Aug 2022 4:30 AM GMTAlthough Ivabradine has been shown to improve clinical outcomes of chronic heart failure but the conventional formulation has the disadvantage of...
JBCPL gets trademark assignment of heart failure drug Azmarda from Novartis Roshni Dhar5 April 2022 12:15 PM GMTJB Chemicals and Pharmaceuticals (JBCPL) has recently announced that the company has approved the assignment of trademark for Azmarda indicated for...
JBCPL gets trademark assignment of HF drug Azmarda from Novartis for Rs 246 crores Ruchika Sharma4 April 2022 5:52 AM GMTMumbai: JB Chemicals and Pharmaceuticals (JBCPL) has recently announced that the company has approved the assignment of trademark for Azmarda...
